[{"NetIncomeLoss_4_FY_USD":-26280470.0,"IncomeTaxReconciliationPriorYearIncomeTaxes_4_FY_USD":373000.0,"IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_4_FY_USD":-5519000.0,"DeferredTaxAssetsUnrealizedCurrencyLosses_0_FY_USD":27000.0,"ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_4_FY_USD":4375025.0,"IncomeTaxReconciliationOtherAdjustments_4_FY_USD":35000.0,"DeferredTaxAssetsOperatingLossCarryforwards_0_FY_USD":23397000.0,"LeaseAndRentalExpense_4_FY_USD":233423.0,"CommonStockSharesIssued_0_FY_shares":62045198.0,"Assets_0_FY_USD":34542197.0,"ShareBasedCompensation_4_FY_USD":4876906.0,"StockIssuedDuringPeriodValueAcquisitions_4_FY_USD":21254298.0,"PreferredStockParOrStatedValuePerShare_0_FY_USD":0.001,"ProceedsFromIssuanceOfCommonStock_4_FY_USD":28754198.0,"IncomeTaxReconciliationStateAndLocalIncomeTaxes_4_FY_USD":-2911000.0,"CommonStockParOrStatedValuePerShare_0_FY_USD":0.001,"AccruedLiabilitiesCurrent_0_FY_USD":3316574.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":58194894.0,"GeneralAndAdministrativeExpense_4_FY_USD":5856609.0,"Liabilities_0_FY_USD":7305628.0,"PrepaidExpenseCurrent_0_FY_USD":443839.0,"IncreaseDecreaseInAccruedLiabilities_4_FY_USD":1800232.0,"GainsLossesOnExtinguishmentOfDebt_4_FY_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_4_FY_pure":0.9599,"CommonStockValue_0_FY_USD":62047.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_4_FY_USD":-8161658.0,"DeferredTaxAssetsOperatingLossCarryforwardsForeign_0_FY_USD":76800000.0,"DeferredTaxAssetsNet_0_FY_USD":0.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_4_FY_USD":7063388.0,"NetCashProvidedByUsedInFinancingActivities_4_FY_USD":28350434.0,"PaymentsOfStockIssuanceCosts_4_FY_USD":403764.0,"IncreaseDecreaseInAccountsPayable_4_FY_USD":465722.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4_FY_pure":0.0157,"CashAndCashEquivalentsAtCarryingValue_0_FY_USD":29249018.0,"AdditionalPaidInCapitalCommonStock_0_FY_USD":186851752.0,"Cash_0_FY_USD":29249018.0,"ForeignCurrencyTransactionGainLossBeforeTax_4_FY_USD":125540.0,"IncreaseDecreaseInPrepaidExpense_4_FY_USD":-57159.0,"CommonStockSharesAuthorized_0_FY_shares":100000000.0,"TaxesExcludingIncomeAndExciseTaxes_4_FY_USD":22664.0,"IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_4_FY_USD":7442000.0,"EffectOfExchangeRateOnCash_4_FY_USD":36000.0,"CommonStockSharesOutstanding_0_FY_shares":62045198.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_FY_shares":500000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4_FY_USD":-26257806.0,"InterestIncomeExpenseNet_4_FY_USD":179973.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4_FY_USD":4876906.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-21287046.0,"AccountsPayableCurrent_0_FY_USD":3989054.0,"PaymentsOfDebtIssuanceCosts_4_FY_USD":0.0,"DebtRelatedCommitmentFeesAndDebtIssuanceCosts_4_FY_USD":0.0,"NonoperatingIncomeExpense_4_FY_USD":4830426.0,"IncomeTaxReconciliationForeignIncomeTaxRateDifferential_4_FY_USD":-723000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_4_FY_shares":10576266.0,"DeferredTaxAssetsInProcessResearchAndDevelopment_0_FY_USD":2069000.0,"CurrentIncomeTaxExpenseBenefit_4_FY_USD":22664.0,"RetainedEarningsAccumulatedDeficit_0_FY_USD":-159677230.0,"DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0_FY_USD":8283000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_4_FY_USD":-18096148.0,"IncomeTaxesReceivable_0_FY_USD":4849340.0,"IncreaseDecreaseInIncomeTaxesReceivable_4_FY_USD":2206595.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4_FY_pure":0.0,"PreferredStockValue_0_FY_USD":0.0,"DeferredIncomeTaxExpenseBenefit_4_FY_USD":22664.0,"LiabilitiesAndStockholdersEquity_0_FY_USD":34542197.0,"PreferredStockSharesAuthorized_0_FY_shares":10000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_4_FY_USD":-26257806.0,"DeferredTaxAssetsGoodwillAndIntangibleAssets_0_FY_USD":132000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_FY_USD":4040812.0,"DeferredTaxAssetsValuationAllowance_0_FY_USD":33991000.0,"DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_0_FY_USD":103100000.0,"OperatingExpenses_4_FY_USD":31088232.0,"EarningsPerShareBasicAndDiluted_4_FY_USD":-0.45,"StockholdersEquity_0_FY_USD":27236569.0,"GainsLossesOnRestructuringOfDebt_4_FY_USD":0.0,"AllocatedShareBasedCompensationExpense_4_FY_USD":4876906.0,"ResearchAndDevelopmentExpense_4_FY_USD":25231623.0,"Ticker":"AVXL","CIK":"1314052","name":"ANAVEX LIFE SCIENCES CORP.","OfficialName":"Anavex Life Sciences Corp. Common Stock","form":"10-K","period":"20200930","fy":"2020.0","fp":"FY","qtrs":"4","uom":"USD","footnote":"nan","Market Cap":"825317693.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20201228"}]